Treatment of kidney cancer during the coronavirus pandemic
COVID-19 continues to affect the care of patients with metastatic [...]
Pazopanib for poor risk kidney cancer patients
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
Outcomes of complete metastasectomy in metastastic kidney cancer
A recent study from Canada investigated the use of surgery [...]
Biomarkers for kidney cancer: current and future strategies
An educational symposium was held from 8-10 August as part [...]
First-line therapy for metastatic kidney cancer: Is two better than one?
An educational symposium was held from 8-10 August as part [...]
What’s next after immunotherapy fails for advanced kidney cancer?
An educational symposium was held from 8-10 August as part [...]
Patterns of initial metastatic recurrence after surgery for high-risk kidney cancer patients
This study looked at where metastases occurred after surgery for [...]
Partial nephrectomy for patients with rare Xp11.2 translocation kidney cancer
XP11.2 translation renal cell carcinoma (RCC) is a very rare [...]
Cabozantinib after immunotherapy in advanced kidney cancer
This recent retrospective study included 84 patients with metastatic renal [...]
Blood tumour biomarker for kidney cancer survival
Researchers are constantly looking for biomarkers to help predict which [...]
